¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽÅÀåÇÐȸ (¿Â¶óÀÎ) KSN-IAC(Integrated Academic Conference) 2021 ÅëÇÕÇмú´ëȸ : 2021-05-08

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѽÅÀåÇÐȸ (¿Â¶óÀÎ) KSN-IAC(Integrated Academic Conference) 2021 ÅëÇÕÇмú´ëȸ : 2021-05-08
±³À°ÀÏÀÚ : 2021-05-08
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) KSN-IAC(Integrated Academic Conference) 2021 ÅëÇÕÇмú´ëȸ      
ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
´ã´çÀÚ : ´ëÇѽÅÀåÇÐȸ
¿¬¶ôó : 02-3486-8736  
À̸ÞÀÏ : ksn@ksn.or.kr      
±³À°Á¾·ù : ³»°úÀÇ»çÇÐ
Âü¼®¿¹»óÀοø : 2000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 50ºÐ  
¼¼ºÎ¼ö°­·á : 80,000¿ø      
ºñ°í 8¸¸¿ø (1ÀÏ µî·Ï½Ã 4¸¸¿ø) : Àü¹®ÀÇ(±³¼ö, ºÀÁ÷ÀÇ, °³¿øÀÇ)/4¸¸¿ø (1ÀÏ µî·Ï½Ã 2¸¸¿ø) : ÀüÀÓÀÇ, Àü°øÀÇ, °£È£»ç, ¾à»ç, ¿µ¾ç»ç, »çȸº¹Áö»ç, ÀÇ·á °ü·Ã Á¾»çÀÚ /¹«·á : ¸¸65¼¼ ÀÌ»ó ȸ¿ø(1956.12.31 ÀÌÀü Ãâ»ý),Çлý(´ëÇпø»ý Á¦¿Ü): ÇлýÁõ »çº» Á¦Ãâ ¡æ ¿Â¶óÀÎ µî·Ï ÈÄ ¸ÞÀÏ·Î Á¦Ãâ ksn@ksn.or.kr      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-08 ROOM3 08:50~09:15 Molecular pathogenesis in Fabry disease  Á¤¼ºÃ¶(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 05-08 ROOM3 09:15~09:40 Modeling of Fabry disease using Patient derived iPSCs and application of gene therapy  Á¤º´ÇÏ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 05-08 ROOM3 09:40~10:05 Pathogenesis and biomarker in Fabry nephropathy  ÃÖ¼öÁ¤(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 05-08 ROOM3 10:05~10:30 Switch to treatment & neutralizing anti-drug antibody in Fabry disease  ±è¼öÇö(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 05-08 ROOM3 10:50~11:15 When to start dialysis in elderly patients with CKD  Çö¿µÀ²(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 05-08 ROOM3 11:15~11:40 Individualized approach to vascular access in accordance with their individual ESKD Life-Plan in elderly patients  ¹Ú¿ì¿µ(°è¸íÀÇ´ë) 
±³À°½Ã°£ 05-08 ROOM3 11:40~12:05 Development of a predictive mortality risk score a Korean eldery dialysis cohort  ±Ç¼øÈ¿(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 05-08 ROOM3 12:05~12:30 Anemia Management Considering the Pathophysiology of Elderly Chronic Kidney Disease Patients  ¾çÀç¿ø(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 05-08 ROOM3 13:40~14:05 Erythropoietin resistance in patients on maintenance dialysis  Á¶ÀåÈñ(°æºÏÀÇ´ë) 
±³À°½Ã°£ 05-08 ROOM3 14:05~14:30 Iron therapy in chronic kidney disease  ¼º¼ö¾Æ(À»ÁöÀÇ´ë) 
±³À°½Ã°£ 05-08 ROOM3 14:30~14:55 Hepcidin in chronic kidney diseas  À¯°æµ·(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 05-08 ROOM3 14:55~15:20 Artificial intelligence for optimal anemia management in end-stage renal disease  À¯ÅÂÇö(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 05-08 ROOM3 15:40~16:10 New evidence for acute management of hyponatremia  ¹é¼±ÇÏ(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 05-08 ROOM3 16:10~16:40 ABPM-guided antihypertensive treatment in CKD  ±èÀ±¹Ì(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 05-08 ROOM3 16:40~17:10 Application of Artificial intelligence in electrolyte and blood pressure disorders  ¿ÀÅ·Å(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 05-08 ROOM3 17:10~17:30 ÆгÎÅäÀÇ  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽÅÀåÇÐȸ (¿Â¶óÀÎ) KSN-IAC(Integrated Academic Conference) 2021 ÅëÇÕÇмú´ëȸ : 2021-05-08""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѼºÇü¿Ü°úÇÐȸ (¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) Á¦11ȸ ±âÃÊÀç°Ç¼ºÇü Çмú´ëȸ : 2021-05-08
´ÙÀ½±Û ´ëÇѽÅÀåÇÐȸ (¿Â¶óÀÎ) KSN-IAC(Integrated Academic Conference) 2021 ÅëÇÕÇмú´ëȸ : 2021-05-08
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 6 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 5 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 4 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 4 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 5 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 4 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 1 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 1 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 1 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 3 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 1 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 1 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 3 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 2 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 2 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷